GeneDx Holdings (WGS) Non-Current Deferred Tax Liability (2022 - 2026)

GeneDx Holdings (WGS) has reported Non-Current Deferred Tax Liability for 5 consecutive years, with $1.4 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Non-Current Deferred Tax Liability rose 21.77% year-over-year to $1.4 million; the TTM figure through Mar 2026 stood at $1.4 million (up 21.77% YoY), while the FY2025 annual figure was $757000.0, down 21.55% from the prior year.
• Non-Current Deferred Tax Liability improved to $1.4 million in Q1 2026 per WGS's latest filing, from $757000.0 in the prior quarter.
• Across five years, Non-Current Deferred Tax Liability topped out at $57.0 million in Q4 2022 and bottomed at $747000.0 in Q2 2025.
• Historically, Non-Current Deferred Tax Liability has averaged $11.5 million across 5 years, with a median of $1.4 million in 2024.
• Annual changes were most pronounced in 2024 — Non-Current Deferred Tax Liability plunged 98.29% — and 2026, when it rose 21.77%.
• GeneDx Holdings' Non-Current Deferred Tax Liability stood at $57.0 million in 2022, then dropped by 0.88% to $56.5 million in 2023, then slumped by 98.29% to $965000.0 in 2024, then decreased by 21.55% to $757000.0 in 2025, then surged by 85.47% to $1.4 million in 2026.
• Business Quant data shows WGS's Non-Current Deferred Tax Liability at $1.4 million in Q1 2026, $757000.0 in Q4 2025, and $1.0 million in Q3 2025.